- Pharmacy Profile Name: Olympia Pharmacy (503A patient-dispensing arm of Olympia Pharmaceuticals)
- Website: olympiapharmacy.com
- Address: 6700 Conroy Road, Suite 155, Orlando, FL 32835
- Phone: 407-420-8208
- CEO: Dr. Mark Mikhael, PharmD
- Co-Founder: Stan Loomis
- Pharmacy Type: 503A state-licensed compounding pharmacy; affiliated FDA-registered 503B outsourcing facility
- Accreditations: LegitScript certified; FDA-registered 503B (cGMP compliant)
- GLP-1 Compounding: Liraglutide (current); formerly semaglutide and tirzepatide during shortage era
- Licensed: 48 states (targeting all 50)
About the Pharmacy
Olympia Pharmacy is the 503A patient-dispensing arm of Olympia Pharmaceuticals, a family-owned compounding operation based in Orlando, Florida. The two entities — Olympia Pharmacy (503A) and Olympia Pharmaceuticals (503B) — operate under the same leadership, website, and facility, but serve distinct regulatory functions.
Olympia Pharmaceuticals is a 503B FDA-registered outsourcing facility licensed to ship medications for office use nationwide. Its affiliated 503A pharmacy, Olympia Pharmacy, extends this service by providing prescription fulfillment — bringing 503B medications directly to patients through their healthcare providers.
Olympia Pharmaceuticals describes itself as the only outsourcing facility in Central Florida and the national leader in compounded medications, with more than 35 years of expertise. It is a family-owned operation led by two generations of pharmacists, with a team comprising pharmacy technicians, pharmacists, microbiologists, and engineers. The CEO, Dr. Mark Mikhael, PharmD, brings over twenty years of pharmacy leadership experience, overseeing a team of engineers, microbiologists, technicians, and pharmacists.
GLP-1 Compounding
Olympia supports long-term weight goals with compounded GLP-1 agonists designed to help regulate appetite, reduce caloric intake, and promote steady, sustainable weight management.
Olympia Pharmacy was among the operations actively fulfilling compounded GLP-1 prescriptions for patients during the semaglutide and tirzepatide shortage era, routing product from its affiliated 503B facility through the 503A patient-dispensing arm. Olympia was one of seven large 503B outsourcing facilities nationally that was actively making compounded tirzepatide at the time the FDA declared the Zepbound shortage resolved in March 2025.
Following the post-shortage enforcement deadlines, Olympia pivoted its GLP-1 strategy: with semaglutide and tirzepatide restricted for 503B production, Olympia launched liraglutide — the first FDA-approved GLP-1 — in two formulas as of June 2025. Liraglutide remains on the FDA shortage list as of early 2026, making compounding of this molecule legally available under current regulations. Patients who received compounded semaglutide or tirzepatide through Olympia Pharmacy during the shortage era and are looking to continue GLP-1 therapy should confirm with their prescribing provider which formulation is currently available.
Type of Pharmacy
The 503A and 503B designations represent two distinct regulatory tracks within the same organizational structure. The 503A arm — Olympia Pharmacy — fills individual patient-specific prescriptions written by licensed providers and ships directly to patients. This is the arm patients interact with when their telehealth provider or physician routes a prescription to Olympia.
The 503B arm — Olympia Pharmaceuticals — produces bulk sterile compounded medications for office use, supplying physician offices, med spas, independent pharmacies, and telehealth platforms without requiring individual patient prescriptions. Product formulated under 503B standards is the source material dispensed through the 503A patient channel.
As a 503B outsourcing facility, Olympia must comply with strict current good manufacturing practice guidelines — the same standards that pharmaceutical manufacturers follow. All compounded drugs are produced under the direct supervision of a licensed pharmacist, and all products are subject to FDA inspection.
Every product is tested and vetted by a third-party lab to meet cGMP and FDA standards before release, with next business day shipping as Olympia’s standard turnaround time.
FDA Form 483 — May 2024: An FDA inspection of the Orlando facility issued a Form 483 in May 2024. The 483 cited failure to identify drug products compounded in the previous six months as required under Section 503B of the FD&C Act — specifically, products compounded were not identified in semi-annual reports from June 2023 and December 2023. This is a reporting compliance finding with no patient safety component identified in public records. No FDA Warning Letter for Olympia was found as of March 2026.
States Licensed In
Olympia is licensed in 48 states, with California and Mississippi identified as the next additions, with a goal of all 50 states by year-end.
Telehealth Providers They Work With
Olympia operates primarily as a B2B supplier to independent pharmacies, physician offices, med spas, and telehealth platforms. The company notes that its weight management products and NAD pair well with telemedicine, with telehealth practices exploring many of its product areas including liraglutide, amino acids, and ED injections. Olympia is LegitScript certified, which it notes is important for telemedicine partners who require that certification. Olympia is also a preferred vendor within the Independent Pharmacy Cooperative (IPC) Vendor Advantage Network. No specific named consumer-facing telehealth platform partnerships were found in public records.
Pricing from Reviews
Olympia sells primarily through provider accounts and pharmacies rather than direct consumer retail. Consumer-facing GLP-1 pricing is not publicly listed on the website. Pricing for patient prescriptions flows through the prescribing provider or telehealth platform rather than appearing as a standalone retail price.
Overall Reviews
Olympia Pharmaceuticals has 28 Trustpilot reviews, with customers consistently praising fast shipping — next-day delivery is a recurring theme — and knowledgeable, responsive customer service staff. Staff members are named individually in positive reviews, and management actively responds to complaints on Trustpilot. Negative reviews reference occasional account processing and shipping issues, each met with a direct management response and resolution.





